chr19-45213209-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382422.1(EXOC3L2):c.2269C>G(p.Pro757Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000643 in 1,611,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001382422.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EXOC3L2 | NM_001382422.1 | c.2269C>G | p.Pro757Ala | missense_variant | 12/12 | ENST00000413988.3 | |
BLOC1S3 | XR_007066811.1 | n.1527-3467G>C | intron_variant, non_coding_transcript_variant | ||||
BLOC1S3 | XR_007066813.1 | n.1499-3467G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EXOC3L2 | ENST00000413988.3 | c.2269C>G | p.Pro757Ala | missense_variant | 12/12 | 5 | NM_001382422.1 | P1 | |
MARK4 | ENST00000587566.5 | c.-276-45780G>C | intron_variant | 5 | |||||
BLOC1S3 | ENST00000591569.1 | n.283-3467G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000487 AC: 74AN: 152104Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000460 AC: 113AN: 245554Hom.: 0 AF XY: 0.000473 AC XY: 63AN XY: 133246
GnomAD4 exome AF: 0.000659 AC: 962AN: 1459254Hom.: 0 Cov.: 32 AF XY: 0.000646 AC XY: 469AN XY: 725932
GnomAD4 genome AF: 0.000487 AC: 74AN: 152104Hom.: 0 Cov.: 31 AF XY: 0.000458 AC XY: 34AN XY: 74294
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1425167). This variant has not been reported in the literature in individuals affected with EXOC3L2-related conditions. This variant is present in population databases (rs142412403, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 364 of the EXOC3L2 protein (p.Pro364Ala). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.1090C>G (p.P364A) alteration is located in exon 10 (coding exon 9) of the EXOC3L2 gene. This alteration results from a C to G substitution at nucleotide position 1090, causing the proline (P) at amino acid position 364 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at